Navigation Links
Long-term exposure to fine particles of traffic pollution increases risk of heart disease
Date:4/17/2013

Rome, 18 April 2013. The association between road traffic and heart disease has been suggested in several studies. In 2012 a large prospective cohort study from Denmark showed that traffic noise was significantly associated with risk of heart attack - for every 10 decibel increase in noise exposure (either at the time of the attack or over the five years preceding it) there was a 12% increased risk.(1)

Now, a new study presented at the EuroPRevent 2013 congress in Rome shows that long-term exposure to fine particle matter (PM) air pollution in part derived from traffic pollution is also associated with atherosclerosis independent of traffic noise.(2)

Details of the study were described by Dr Hagen Klsch from West-German Heart Center in Essen, Germany, who explained that the study was designed to establish where responsibility for the increased heart risks associated with traffic actually lay - with noise or particle pollution, or both.

The study was based on data from the German Heinz Nixdorf Recall Study, a population-based cohort of 4814 participants with a mean age of 60 years. Their proximity to roads with high traffic volume was calculated with official street maps, their long-term exposure to particle pollutants assessed with a chemistry transport model, and road traffic noise recorded by validated tests. The participants' level of atherosclerosis was evaluated by measurement of vascular vessel calcification in the thoracic aorta, a common marker of subclinical atherosclerosis (known as TAC), by computed tomography imaging.

Results showed that in the 4238 subjects included in the study small particulate matter (designated as PM2.5) and proximity to major roads were both associated with an increasing level of aortic calcification - for every increase in particle volume up to 2.4 micrometers (PM2.5) the degree of calcification increased by 20.7% and for every 100 metre proximity to heavy traffic by 10%. The study also found a borderline increase in TAC for night time noise (of 3.2% per 5 decibels). The associations of PM2.5 and road traffic noise were not modified by each other.

Commenting on the results, Dr Klsch confirms that long-term exposure to fine PM air pollution and to road traffic noise are both independently associated with TAC as a measure of subclinical atherosclerosis.

"These two major types of traffic emissions help explain the observed associations between living close to high traffic and subclinical atherosclerosis," he says. "The considerable size of the associations underscores the importance of long-term exposure to air pollution and road traffic noise as risk factors for atherosclerosis."

Fine PM and traffic noise are believed to act through similar biologic pathways, thereby increasing cardiovascular risk; they both cause an imbalance in the autonomic nervous system, which feeds into the complex mechanisms regulating blood pressure, blood lipids, glucose level, clotting and viscosity.

TAC, alongside coronary artery calcification (CAC), is a reliable marker of subclinical atherosclerosis. While sharing cardiovascular risk factors with coronary atherosclerosis, TAC like TAC has been shown to be independently related to the incidence of cardiovascular events.

A further study reported at this congress from French investigators found that all the main air pollutants (carbon monoxide (CO), nitrogen dioxide (NO2), sulphur dioxide (SO2), and particulate matter measured as PM10 or PM2.5, but with the exception of ozone (O3)) were significantly associated with an increased risk of myocardial infarction.(3)


'/>"/>

Contact: Jacqueline Partarrieu
press@escardio.org
33-492-947-756
European Society of Cardiology
Source:Eurekalert

Related biology news :

1. Long-term research reveals causes and consequences of environmental change
2. Sexual reproduction brings long-term benefits, study shows
3. Long-term preservation: Pensoft Publishers partner with the CLOCKSS Archive
4. Model forecasts long-term impacts of forest land-use decisions
5. Study shows long-term effects of radiation in pediatric cancer patients
6. Is long-term weight loss possible after menopause?
7. New long-term antimicrobial catheter developed
8. Preeclampsia poses a significant long-term health risk according to new research from Ben-Gurion U.
9. Preemies brains reap long-term benefits from Kangaroo Mother Care
10. Site-specific, long-term research expanding understanding of climate change
11. Tsunami caused long-term ecosystem change in the Caribbean
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2017)... WASHINGTON , Feb. 27, 2017   Strategic ... fund, today announced it has led a $3.5 million investment ... collaboration platform. Strategic Cyber Ventures is DC based and ... and Hank Thomas . Ron Gula , ... Tech Ventures, also participated in this series A round ...
(Date:2/24/2017)... , Feb. 24, 2017  EyeLock LLC, a leader of ... elite iris biometric solution on the latest Qualcomm® ... at Mobile World Congress 2017 (February 27 ... in Hall 3, Stand 3E10. ... Haven™ security platform—a combination of hardware, software ...
(Date:2/21/2017)... ARMONK, N.Y. and PORTLAND, Ore. ... IBM ) and the Avamere Family of Companies (Avamere ... Care) today announced a six-month research study that will ... caregivers improve eldercare at senior living and health centers. ... facilities, Avamere hopes to gain insights into physical and ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... ... March 23, 2017 , ... AxioMed president, Jake Lubinski, describes ... characteristics when deformed, which is identical to how the human discs work to ... and return to its natural state along a hysteresis curve, exactly like a ...
(Date:3/23/2017)... 23, 2017  SeraCare Life Sciences, Inc., a ... vitro diagnostics manufacturers and clinical laboratories, is ... multiplexed Inherited Cancer reference material ... next-generation sequencing (NGS). The Seraseq™ Inherited Cancer DNA ... from industry experts to validate the ability ...
(Date:3/23/2017)... March 23, 2017 Kineta, Inc., a ... novel therapies in immuno-oncology, today announced the discovery ... molecule compounds that activate interferon response factor 3 ... demonstrate immune-mediated tumor regression in a murine colon ... who demonstrated complete tumor regression to initial drug ...
(Date:3/23/2017)... , March 23, 2017 In ... four equities in the Biotech industry: Sangamo Therapeutics Inc. ... Inc. (NYSE MKT: SYN), and Regulus Therapeutics Inc. (NASDAQ: ... , 2017, Credit Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from ... their free report at: ...
Breaking Biology Technology: